The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 3-11D MDS：AZA Treatment

Sun. Oct 13, 2019 3:40 PM - 4:40 PM No.11 (Tokyo International Forum, 5F G502)

Chair: Tomoko Hata (Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University)

[OS3-11D-4] A retrospective study of 132 MDS patients receiving azacitidine therapy

Aya Nakano1, Takeshi Saito1, Hiroki Yokoyama1, Atsushi Katsube1, Hiroto Ishii1, Tadahiro Gunji1, Sayaka Oshima1, Shoko Ishii1, Riku Nagao1, Noriko Usui2, Kaichi Nishiwaki3, Nobuaki Dobashi2, Shingo Yano1 (1.Clinical Oncol/Hematol, the Jikei Univ Hosp., Tokyo, Japan, 2.Clinical Oncol/Hematol, the Jikei Univ Daisan Hosp., Tokyo, Japan, 3.Clinical Oncol/Hematol, the Jikei Univ Kashiwa Hosp., Chiba, Japan)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password